NO914567L - ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIDYL DERIVATIVES - Google Patents

ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIDYL DERIVATIVES

Info

Publication number
NO914567L
NO914567L NO91914567A NO914567A NO914567L NO 914567 L NO914567 L NO 914567L NO 91914567 A NO91914567 A NO 91914567A NO 914567 A NO914567 A NO 914567A NO 914567 L NO914567 L NO 914567L
Authority
NO
Norway
Prior art keywords
thromboxane
addition
preparation
pyridyl derivatives
therapeutic active
Prior art date
Application number
NO91914567A
Other languages
Norwegian (no)
Other versions
NO175634B (en
NO914567D0 (en
NO175634C (en
Inventor
Rainer Soyka
Wolfgang Eisert
Thomas Mueller
Johannes Weisenberger
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO914567D0 publication Critical patent/NO914567D0/en
Publication of NO914567L publication Critical patent/NO914567L/en
Publication of NO175634B publication Critical patent/NO175634B/no
Publication of NO175634C publication Critical patent/NO175634C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Paper (AREA)

Abstract

The present invention relates to novel pyridyl derivatives of the general formula <IMAGE> in which R1 to R6, A, X and n are as defined in Claim 1, their enantiomers, their cis- and trans-isomers if R4 and R5 together represent a carbon-carbon bond, and their addition salts, for pharmaceutical use, in particular, their physiologically tolerable addition salts with inorganic or organic bases, if R6 represents a hydroxyl group, which have useful pharmacological properties, in particular antithrombotic effects and effects mediated by thromboxane. In addition, the novel compounds are at the same time thromboxane antagonists (TRA) and thromboxane synthesis inhibitors (TSH). In addition, they also have an effect on PGE2 production.
NO914567A 1990-11-22 1991-11-21 Analogous Process for Preparing Therapeutically Active Pyridyl Derivatives NO175634C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4037112A DE4037112A1 (en) 1990-11-22 1990-11-22 NEW PYRIDYL DERIVATIVES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF

Publications (4)

Publication Number Publication Date
NO914567D0 NO914567D0 (en) 1991-11-21
NO914567L true NO914567L (en) 1992-05-25
NO175634B NO175634B (en) 1994-08-01
NO175634C NO175634C (en) 1994-11-09

Family

ID=6418696

Family Applications (1)

Application Number Title Priority Date Filing Date
NO914567A NO175634C (en) 1990-11-22 1991-11-21 Analogous Process for Preparing Therapeutically Active Pyridyl Derivatives

Country Status (19)

Country Link
EP (1) EP0487095B1 (en)
JP (1) JPH04275273A (en)
KR (1) KR920009799A (en)
AT (1) ATE134619T1 (en)
AU (1) AU640063B2 (en)
CA (1) CA2055950A1 (en)
DE (2) DE4037112A1 (en)
DK (1) DK0487095T3 (en)
ES (1) ES2084756T3 (en)
FI (1) FI915484A (en)
GR (1) GR3019783T3 (en)
HU (1) HU213676B (en)
IE (1) IE74248B1 (en)
IL (1) IL100097A (en)
NO (1) NO175634C (en)
NZ (1) NZ240677A (en)
PT (1) PT99571B (en)
RU (1) RU2028292C1 (en)
ZA (1) ZA919205B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4216364A1 (en) * 1991-12-14 1993-11-25 Thomae Gmbh Dr K Pyridyl derivs. with antithrombotic properties
AR028110A1 (en) * 2000-06-02 2003-04-23 Astrazeneca Ab NEW PROCESS
DE10225635C1 (en) * 2002-06-07 2003-12-24 Aventis Pharma Gmbh N-benzoylureido-cinnamic acid derivatives, process for their preparation and their use
FI20055498A0 (en) * 2005-09-16 2005-09-16 Biotie Therapies Corp Sulfonamides
US20150315130A1 (en) * 2012-12-10 2015-11-05 H. Lundbeck A/S New positive allosteric modulators of nicotinic acetylcholine receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518602A (en) * 1982-10-07 1985-05-21 Takeda Chemical Industries, Ltd. Vinyl carboxylic acid derivatives, their production and use as inhibitors of thromboxane synthetase
GB8708233D0 (en) * 1987-04-07 1987-05-13 Smith Kline French Lab Pharmaceutically active compounds
DE3932403A1 (en) * 1989-05-12 1991-04-11 Thomae Gmbh Dr K NEW ARYLSULFONAMIDES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
AU640063B2 (en) 1993-08-12
IL100097A0 (en) 1992-08-18
ZA919205B (en) 1993-05-21
ATE134619T1 (en) 1996-03-15
FI915484A (en) 1992-05-23
GR3019783T3 (en) 1996-07-31
CA2055950A1 (en) 1992-05-23
NO175634B (en) 1994-08-01
NZ240677A (en) 1994-12-22
FI915484A0 (en) 1991-11-21
IE914048A1 (en) 1992-06-03
PT99571B (en) 1999-04-30
EP0487095B1 (en) 1996-02-28
HUT60472A (en) 1992-09-28
NO914567D0 (en) 1991-11-21
DK0487095T3 (en) 1996-06-24
HU913644D0 (en) 1992-02-28
JPH04275273A (en) 1992-09-30
HU213676B (en) 1997-09-29
NO175634C (en) 1994-11-09
IL100097A (en) 1995-07-31
DE4037112A1 (en) 1992-05-27
DE59107462D1 (en) 1996-04-04
ES2084756T3 (en) 1996-05-16
KR920009799A (en) 1992-06-25
AU8796491A (en) 1992-05-28
IE74248B1 (en) 1997-07-16
RU2028292C1 (en) 1995-02-09
PT99571A (en) 1992-10-30
EP0487095A1 (en) 1992-05-27

Similar Documents

Publication Publication Date Title
NO902099D0 (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ARYLSULPHONAMIDES.
DE69131359D1 (en) Condensed thiazole compounds, their preparation and their application
DE59202241D1 (en) New pyridyl derivatives, pharmaceutical compositions containing these compounds and process for their preparation.
NO914567L (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIDYL DERIVATIVES
ATE445589T1 (en) NEW RETINOID DERIVATIVES AND AN ANTI-CANCER PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS
FI891807A (en) Process for the preparation of therapeutically active octahydropyrrolo-pyrazino / 2,1-i / indol-2-one derivatives
NO20020475D0 (en) 2-aminotetraline derivatives for glaucoma therapy
FR2655042B1 (en) NOVEL SUBSTITUTED BENZOTHIAZOLINONES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
NO169841C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF NEW, THERAPEUTIC ACTIVE (ARYLPHENYL OR THIENYLMETHYL) -2,2&#39;-BI-1H IMIDAZOLES